Merck Recalls Chemotherapy Drugs Due to Faulty Child-Safe Caps
A faulty cap is forcing a recall from one national pharmacy.
Merck Sharp & Dohme Corp., of Whitehouse Station, NJ, is issuing the recall for Temodar (Temozolomide) and Temozolomide (generic). The bottle cap can be cracked which can cause the child-resistant closure to become ineffective to young children who can gain unintended access to the capsules, posing a risk of poisoning.
Temodar and Temozolomide are oral chemotherapy drugs. The capsules were distributed in 5- and 14-count brown glass bottles that have white plastic child-resistant caps. A white label affixed to the bottle has the word "Temozolomide" printed in black lettering. About 276,000 bottles are subject to the recall.
No incidents or adverse reactions have been reported to date. Consumers should immediately inspect their bottle caps for cracks. If a crack is found, consumers should contact Merck for a replacement cap. Consumers may continue to use the drug as directed.
The prescription drugs were sold at clinics and pharmacies nationwide from July 2013 to August 2015.
Consumers with questions can contact Merck Sharp & Dohme at (800) 943-8069.